Medication Monitor

Generic Name (Trade Name—Company)
August 29, 2011


(EpiPen, EpiPen Jr—Dey Pharma)
Dual packs align with practice guidelines


Emergency treatment of anaphylaxis

Dey Pharma announced a transition from distributing and marketing single sizes of EpiPen and EpiPen Jr Auto-Injectors in the U.S. and instead will market 2-packs of of these products. This decision was made to encourage physicians and patients to follow recommendations by the National Institute of Allergy and Infectious Diseases, which state that patients at risk for or who have experienced anaphylaxis have immediate access to two doses of epinephrine. Specifically, the guidelines state that if a patient responds poorly to the initial dose or has ongoing or progressive symptoms despite initial dosing, repeated dosing may be required after 5 to 15 minutes.

The manufacturer noted that there are no safety issues with the single package sizes and these products may still be available at certain pharmacies for a few weeks until their stock is depleted. The single package sizes will continue to be available outside of the U.S.